The problems are: 1) restructuring continues notwithstanding what Jure said years back that they were finished with them, 2) every other quarter there are execution issues or customer defaults, 3) the weak demand reflects also competition from the likes of JBL and FLEX. Jure always sugar-coat the outlook 2 quarters hence, and this sugar coat turns in most cases into manure.
If there is a large market correction, you will be able to buy the stock below $7. A small correction, below $8, Otherwise, $8.5 to $9.5. The stock is selling below tangible book, and cash flow is still positive but there is no growth and the competition is not standing still.